Streetbeat News

Stock Prices

INOD

JCapital Research has issued a report on Innodata, titled 'More than a promote: 'Mag 7' agreements likely smaller than claimed, revenue and costs both look highly exaggerated'. The report suggests that Innodata's agreements and financial figures may be overstated.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:58 pm

WHLR

The trading halt status was updated at 8:55:00 AM ET, indicating a quotation resumption. This update is relevant for investors tracking trading activities and potential impacts on stock prices.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:55 pm

KSPI

NCPL

RELI

The article highlights three oversold financial stocks with potential for short-term gains: Netcapital Inc (NCPL), Reliance Global Group Inc (RELI), and Kaspi.kz AO (KSPI). These stocks have low RSI values, indicating they may be undervalued. NCPL reported a significant quarterly loss, RELI updated on a pending acquisition, and KSPI was impacted by a research report.

Portfolio Pulse from Avi Kapoor

September 20, 2024 | 12:50 pm

BSY

CLH

The Nasdaq 100 rose by 2.5%, with investors focusing on insider trades. Notable sales include Bentley Systems' Chief Product Officer selling shares and Clean Harbors' Director selling shares. Insider sales can indicate concerns or overvaluation but should not be the sole basis for investment decisions.

Portfolio Pulse from Avi Kapoor

September 20, 2024 | 12:49 pm

NVO

Novo Nordisk announced positive results from its Phase 2a trial of Monlunabant, a drug for obesity, showing significant weight loss. The company plans to initiate a Phase 2b trial in 2025.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:47 pm

CDRE

CELH

GNTX

VKTX

Jim Cramer recommends buying Viking Therapeutics due to its strong prospects. JPMorgan has an Overweight rating on Viking with a price target of $80. Gentex is struggling due to its ties to the auto industry. Cadre Holdings reported strong earnings, while Celsius Holdings faces unspecified issues.

Portfolio Pulse from Avi Kapoor

September 20, 2024 | 12:46 pm

NIO

VLKAF

NIO Inc. has denied rumors of plans to take over the Audi Brussels car plant. Despite media reports of a NIO delegation visiting the plant, the company clarified it has no intentions to pursue such a takeover. NIO's shares are trading slightly lower in the premarket.

Portfolio Pulse from Nabaparna Bhattacharya

September 20, 2024 | 12:42 pm

DRI

Darden Restaurants, Inc. (NYSE:DRI) reported weaker-than-expected Q1 results, missing both earnings and sales estimates. Despite this, the company announced a quarterly dividend and saw its stock price rise by 8.3%. Analysts have revised their price targets, with mixed ratings ranging from Hold to Outperform.

Portfolio Pulse from Avi Kapoor

September 20, 2024 | 12:40 pm

FBIO

Fortress Biotech shares declined following the announcement of an $8 million registered direct offering and concurrent private placements.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:34 pm

FBIO

Fortress Biotech has announced an $8 million registered direct offering, pricing 3,939,394 shares at $1.65 each. Concurrently, the company will issue warrants in private placements for the same number of shares at $1.84 per share.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 12:33 pm